Amerigo Scientific Releases Transglutaminase Inhibitors to Unlock Their Therapeutic Potential in Diseases
Amerigo Scientific announces its transglutaminase inhibitors, designed to advance research into their therapeutic applications across a range of diseases. NEW YORK, NY, UNITED STATES, February 27, 2025 /EINPresswire.com/ -- Amerigo Scientific releases …